Feb. 2021 | Pharnext Announces Financing of €11 Million Through a Capital Raise Subscribed by Existing Shareholders and a Convertible Bonds Issued to European Investors; European Investors Also Provide Indication of Interest for an Additional Amount of up to €25 Million in Convertible Bonds
Jan. 2021 | Adocia Announces Positive Clinical Results Confirming the Ultra-Rapid Profile of a BioChaperone® Lispro Formulation Containing Insulin from Partner Tonghua Dongbao
Nov. 2020 | IPF Partners announces Final Close of its second Healthcare Growth Debt Fund at c. €187m, well over the initial €140m target
